Patent · US Active

Three-dimensional structure of complement receptor type 2 and uses thereof

US8858945B2 · kind B2 · utility

0Cited by
24References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2013
Grant dateOct 14, 2014
Priority date
Expiry dateJun 13, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2299/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a crystalline human CR2 protein in complex with C3d, and the three dimensional structure of the crystalline complex. Also disclosed are methods of use of the structure, particularly for structure-based identification of compounds that bind to CR2 and inhibit or enhance the binding of CR2 to a natural ligand, that bind to CR2 and agonize or antagonize the receptor, that bind to CR2 and inhibit or enhance CR2 dimerization, or that use the C3-binding ability of CR2 as a drug delivery vehicle. Also disclosed are therapeutic compounds obtained by such methods and uses for such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.